Inhibition of menin, BCL-2, and FLT3 combined with a hypomethylating agent cures NPM1/FLT3-ITD/-TKD mutant acute myeloid leukemia in a patient-derived xenograft model

Detalles Bibliográficos
Autores principales: Carter, Bing Z., Mak, Po Yee, Tao, Wenjing, Ostermann, Lauren B., Mak, Duncan H., Ke, Baozhen, Ordentlich, Peter, McGeehan, Gerard M., Andreeff, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483344/
https://www.ncbi.nlm.nih.gov/pubmed/36727398
http://dx.doi.org/10.3324/haematol.2022.281927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483344/
https://www.ncbi.nlm.nih.gov/pubmed/36727398
http://dx.doi.org/10.3324/haematol.2022.281927

Ejemplares similares